A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for infants on life support with severe bronchiolitis—a seasonal viral ...

Nirsevimab immunisation reduces bronchiolitis-related hospitalisations among infants younger than 3 months, a new study finds.

For infants and children hospitalized with respiratory syncytial virus infection, ziresovir reduces signs and symptoms of bronchiolitis.

For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and symptoms of bronchiolitis, according to a study published in the Sept. 26 ...

The cough related to bronchitis can be persistent and uncomfortable. It may last for many days and may produce mucus of varying colors. Learn more here.

Bronchiolitis, primarily caused by RSV, is a serious respiratory condition in infants that can lead to severe mucus build-up and breathing difficulties. Pediatrician Cindy Gellner, MD explains how ...

RSV testing among infants has increased since 2015, with significant growth post-COVID-19, yet outpatient testing remains low. The study analyzed 20,752 bronchiolitis encounters across four ...

Bronchiolitis cases dropped significantly during the COVID-19 lockdown, leading to fewer wheezing episodes and reduced respiratory medication use in children.

RSV (respiratory syncytial virus) causes lung infections, especially in infants, which can lead to diseases such as bronchiolitis and pneumonia.

PICU Use for Bronchiolitis Tied to 'Striking' Rise in Noninvasive Breathing Support — Multiple factors appear to be behind jump in high-flow nasal cannula, noninvasive ventilation use ...